News and Press Releases

Tracey Marantal Joins Worldwide Clinical Trials as President, Oncology Business Unit

Proven clinical operations leader joins global CRO to lead high-performing therapeutic team and drive strategy for growing oncology portfolio 24 September 2024 -- North Carolina, US -- Tracey Marantal has...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024

600 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 USA

ETIHAD CARGO CELEBRATES 20 YEARS OF SUCCESSFUL OPERATIONS IN INDIA 

Etihad Cargo is celebrating 20 years of operations in India, reflecting its long-term commitment to the market. The airline has significantly expanded its presence, offering belly hold capacity via nonstop...

Category: Logistics
Posted: September 24, 2024

RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System

First-in-human cases successfully completed using this new system at Baptist Health, Jacksonville, Florida 23 September 2024, – London, UK – RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK...

Category: Biotechnology, Clinical Trials
Posted: September 23, 2024

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in adults and adolescents...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 20, 2024

The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG

DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma

Recommendation supported by findings from quadruplet therapy PERSEUS study with daratumumab subcutaneous (SC) formulation in the frontline setting Findings showed 60 percent reduction in risk of disease progression or death...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 20, 2024

Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

Professor V. A. Bumelis opens the Lithuanian Museum of Biotechnology

20 September 2024 – Savaitiskes, Lithuania –The 40th anniversary of the Lithuanian biopharmaceutical industry and science was marked on Monday with the opening of the Lithuanian Biotechnology Museum in the...

Category: Biotechnology, Other
Posted: September 20, 2024

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease

19 September 2024 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: September 19, 2024

Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom

AGREEMENT WITH RECURSION PHARMACEUTICALS

New pharma agreement for Parsortix CTC analysis 19 September 2024 -- Guilford, UK -- ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: September 19, 2024

2 Occam Court, Occam Road, Surrey Research Park, Guilford, GU2 7QB

Headlands Research to Open New Clinical Research Site in El Paso, Texas

Office will be led by Dr. Ryan Casey, a family medicine clinician experienced in treating underserved communities along the US southern border region 19 September 2024 -- California, US --...

Category: Clinical Trials, Drug Discovery
Posted: September 19, 2024

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates

19 September 2024 -- London, UK -- Vidac Pharma Holdings Plc, a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces that the United States Patent and...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 19, 2024

Vidac Pharma Holding PLC, Dr. Max Herzberg, 20-22 Wenlock Road, London N1 7GU, United Kingdom

ETIHAD CARGO AND SF AIRLINES TO STRENGTHEN UAE-CHINA TRADE WITH JOINT VENTURE COMMITMENT

Etihad Cargo and SF Airlines have announced a project to establish a first-of-its-kind joint venture with the aim of promoting economic and trade cooperation and enhancing global logistics and connectivity....

Category: Logistics
Posted: September 19, 2024

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders 18 September 2024 -- Utah, US, and Oxford, UK -- PrecisionLife, a leading clinical-stage precision...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024

8b Bankside Hanborough Business Park Oxford, OX29 8LJ

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target. 18...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024

Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems

Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...

Category: Drug Delivery, Manufacturing and Packing, Other
Posted: September 18, 2024

Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic AD FDA Fast Track...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 17, 2024

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland